| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.01 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.43 | 0.01 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |